Kei Nomura

10PUBLICATIONS
9CO-AUTHORS
Food properties (incl. characteristics and health benefits)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical microbiology not elsewhere classifiedPredictive and prognostic markersMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 28, 2025
Hydrogen Gas Inhalation Improved Intestinal Microbiota in Ulcerative Colitis: A Randomised Double-Blind Placebo-Controlled Trial.

Takafumi Maruyama, Dai Ishikawa, Rina Kurokawa

|Sep 28, 2024
Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study.

Kei Nomura, Tomoyoshi Shibuya, Rina Odakura

|Jun 27, 2024
Residual Recurrence of a Small Intestinal Capillary Hemangioma with Obscure Gastrointestinal Bleeding Treated by Double-Balloon Endoscopy: A Case Report and Literature Review.

Kei Nomura, Tomoyoshi Shibuya, Arisa Yuzawa

|May 25, 2024
Remission Factors for Ustekinumab Treatment of Ulcerative Colitis: A Multicenter Retrospective Study of Real-World Data in Japan.

Masashi Omori, Tomoyoshi Shibuya, Hirotaka Ishino

|Mar 29, 2023
Enterolith Treated with a Combination of Double-Balloon Endoscopy and Cola Dissolution Therapy.

Kei Nomura, Tomoyoshi Shibuya, Masashi Omori

|Oct 27, 2022
Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis.

Keiichi Haga, Tomoyoshi Shibuya, Taro Osada

Pageof 2

Frequent Collaborators

10 joint publications

Dai Ishikawa

10 joint publications

Tomoyoshi Shibuya

9 joint publications

Akihito Nagahara

5 joint publications

Mayuko Haraikawa